Abstract
Urticaria is often classified as acute, chronic, or physical based on duration of symptoms and the presence or absence of inducing stimuli. Urticarial vasculitis, contact urticaria, and special syndromes are also included under the broad heading of urticaria. Recent advances in our understanding of the pathogenesis of chronic urticaria include the finding of autoantibodies to mast cell receptors in nearly half of patients with chronic idiopathic urticaria. These patients may have more severe disease and require more aggressive therapies. Extensive laboratory evaluation for patients with chronic urticaria is typically unrevealing and there are no compelling data that associate urticaria with chronic infections or malignancy. Pharmacologic therapy consists primarily of the appropriate use of first- and second-generation histamine H1 receptor antihistamines. Additional therapy may include leukotriene receptor antagonists, corticosteroids, and immunomodulatory agents for severe, unremitting disease. Despite our greater understanding of the pathogenesis of urticaria, the condition remains a frustrating entity for many patients, particularly those with chronic urticaria.
Similar content being viewed by others
References
Rook A. The historical background. In: Warin RP, Champion RH. Urticaria. London: Saunders, 1974: 1–9
Humphreys F. Major landmarks in the history of urticarial disorders. Int J Dermatol 1997; 36: 793–6
Czarnetzki BM. The history of urticaria. Int J Dermatol 1989; 28 (1): 52–7
Grattan C, Black AK. Urticaria and angioedema. In: Bolognia JL, Jorrizo JL, Rapini RP, editors. Dermatology. Vol. 1. London: Elsevier, 2003: 287–302
Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000; 105: 664–72
Schafer T, Ring I. Epidemiology of urticaria. In: Burr ML, editor. Epidemiology of clinical allergy: monographs in allergy. Basel: Karger, 1993: 49–60
Paul E, Greilich KD, Dominante G. Epidemiology of urticaria. Monogr Allergy 1987; 21: 87–115
Mortureux P, Leaute-Labreze C, Legrain-Lifermann V, et al. Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol 1998; 134: 319–23
Grob J, Revuz J, Ortonne JP, et al. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 2005; 152: 289–95
Dice JP. Physical urticaria. Immunol Allergy Clin North Am 2004; 24 (2): 225–46
Lipsker D, Spehner D, Drillien R, et al. Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions. Br J Dermatol 2000; 142 (5): 954–9
Saurat JH, Schifferli J, Steiger G, et al. Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition: higher frequency in Schnitzler’s syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 1991; 88 (2): 244–56
Asli B, Bienvenu B, Cordoliani F, et al. Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome). Arch Dermatol 2007; 143 (8): 1046–50
Kanazawa N, Furukawa F. Autoinflammatory syndromes with a dermatological perspective. J Dermatol 2007; 34: 601–18
Matz H, Orion E, Wolf R. Pruritic urticarial papules and plaques of pregnancy: polymorphic eruption of pregnancy (PUPPP). Clin Dermatol 2006; 24: 105–8
Jorrizo J. Approach to the chronic urticaria patient. Texas Dermatologic Society meeting; 2004 May 15; Austin (TX)
Wisnieski JJ. Urticarial vasculitis. Curr Opin Rheumatol 2000; 12: 24–31
Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. New Engl J Med 1993; 328: 1599–604
Greaves MW. Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 2003; 3: 363–8
Venarske D, de Shazo RD. Molecular mechanisms of allergic disease. South Med J 2003; 96: 1049–54
Buhner S, Reese I, Kuehl F, et al. Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability. Allergy 2004; 59: 1118–23
Powell RJ, Du Toit GL, Siddique N, et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007; 37: 631–50
Kaplan AP, Finn A. Autoimmunity and the etiology of chronic urticaria. Can J Allergy Clin Immunol 1999; 4: 286–92
Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989; 84: 66–71
O’Donnell BF, Francis DM, Swana GT, et al. Thyroid autoimmunity in chronic urticaria. Br J Dermatol 2005; 153: 331–5
Bakos N, Hillander M. Comparison of chronic autoimmune urticaria with chronic idiopathic urticaria. Int J Dermatol 2003; 42: 613–5
Zauli D, Grassi A, Ballardini G, et al. Thyroid autoimmunity in chronic idiopathic urticaria. Am J Clin Dermatol 2002; 3: 525–8
Fusari A, Colangelo C, Bonifazi F, et al. The autologous serum skin test in the follow-up of patients with chronic urticaria. Allergy 2005; 60: 256–8
Sabroe RA, Seed PT, Francis DM, et al. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-Fc epsilon RI or anti-IgE autoantibodies. J Am Acad Dermatol 1999; 40: 443–50
Asero R, Orsatti A, Tedeschi A, et al. Autoimmune chronic urticaria associated with type 1 diabetes and Graves’ disease. J Allergy Clin Immunol 2005; 115: 1088–9
Hizal M, Tuzan B, Wolf R, et al. The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int J Dermatol 2000; 39: 443–5
Hook-Nikanne J, Varjonen E, Harvima RJ, et al. Is Helicobacter pylori infection associated with chronic urticaria? Acta Derm Venereol 2000; 80 (6): 425–6
Federman DG, Kirsner RS, Moriarty JP, et al. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003; 49: 861–4
Magen E, Mishal J, Schlesinger M, et al. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. Helicobacter 2007; 12 (5): 567–71
Baskan EB, Turker T, Gulten M, et al. Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria. Int J Dermatol 2005; 44 (12): 993–5
Fukuda S, Shimoyama T, Umegaki N, et al. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol 2004; 39 (9): 827–30
Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs 2004; 64: 2515–36
Grattan C, Powell S, Humphreys F, et al. Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol 2001; 144: 708–14
Wedi B, Raap U, Kapp A. Chronic urticaria and infections. Curr Opin Allergy Clin Immunol 2004; 4: 387–96
Daschner A, Vega de la Osada F, Pascual CY. Allergy and parasites reevaluated:wide-scale induction of chronic urticaria by the ubiquitous fish-nematode Anisakis simplex in an endemic region. Allergol Immunopathol (Madr) 2005; 33: 31–7
Daschner A, Pascual CY. Anisakis simplex: sensitization and clinical allergy. Curr Opin Allergy Clin Immunol 2005; 5: 281–5
Kanazawa K, Yaoita H, Tsuda F, et al. Hepatitis C virus infection in patients with urticaria. J Am Acad Dermatol 1996; 35: 195–8
Cribier BJ, Santinelli F, Schmitt C, et al. Chronic urticaria is not significantly associated with hepatitis C or hepatitis G infection: a case control study. Arch Dermatol 1999; 135 (11): 1335–9
Asero R. Chronic idiopathic urticaria: a family study. Ann Allergy Asthma Immunol 2002; 89: 195–6
O’Donnell BF, O’Neill CM, Francis DM, et al. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999; 140: 853–8
Maxwell DL, Atkinson BA, Spur BW, et al. Skin responses to intradermal histamine and leukotrienes C4, D4, and E4 in patients with chronic idiopathic urticaria and in normal subjects. J Allergy Clin Immunol 1990; 86: 759–65
Caproni M, Cardinali C, Giomi B, et al. Serological detection of eotaxin, IL-4, IL-13, IFN-gamma, MIP-1alpha, TARC and IP-10 in chronic autoimmune urticaria and chronic idiopathic urticaria. J Dermatol Sci 2004; 36: 57–9
Caproni M, Giomi B, Volpi W, et al. Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals. Clin Immunol 2005; 114: 284–92
Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004; 114: 465–74
Kessel A, Bishara R, Amital A, et al. Increased plasma levels of matrix metal-loproteinase-9 are associated with the severity of chronic urticaria. Clin Exp Allergy 2005; 35: 221–5
Tedeschi A, Lorini M, Asero R. No evidence of increased serum substance P levels in chronic urticaria patients with and without demonstrable circulating vasoactive factors. Clin Exp Derm 2005; 30: 171–5
Kikuchi Y, Kaplan AP. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 2002; 109: 114–8
Soundararajan S, Kikuchi Y, Joseph K, et al. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol 2005; 115: 815–21
Asero R, Madonini E. Bronchial hyperresponsiveness is a common feature in patients with chronic urticaria. J Invest Allerg Clin Immunol 2006; 16 (1): 19–23
Sabroe RA, Francis DM, Barr RM, et al. Anti-FcεRI autoantibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 1998; 102: 651–8
Kaplan AP, Joseph K, Shibayama Y, et al. Bradykinin formation: plasma and tissue pathways and cellular interactions. In: Gallin J, Snyderman R, editors. Inflammation: basic principles and clinical correlates. 3rd ed. Philadelphia (PA): Lippincott, Williams and Wilkins, 1999: 331–47
Schaeffer RC, Gong F, Bitrick MS, et al. Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms. Am J Physiol 1993; 264: 1798–809
Asero R, Tedeschi A, Riboldi P, et al. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117 (5): 1113–7
Kozel MM, Moein MC, Mekkes JR, et al. Evaluation of a clinical guideline for the diagnoses of physical and chronic urticaria and angioedema. Acta Derm Venereol 2002; 82: 270–4
Kozel MM, Mekkes JR, Bossuyt PM, et al. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 1998; 134: 1575–80
Kozel MM, Bossuyt PM, Mekkes JR, et al. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review. J Am Acad Dermatol 2003; 48: 409–16
Grattan CE, Walpole D, Francis DM, et al. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997; 27: 1417–24
Grattan CE, Dawn G, Gibbs S, et al. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 2003; 33: 337–41
Leurs R, Church MK, Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 2002; 32: 489–98
Thomson L, Blaylock MG, Sexton DW, et al. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 2002; 32: 1187–92
Gillard M, Strolin Benedetti M, Chatelain P, et al. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines. Inflamm Res 2005; 54: 367–9
Asero R. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses. Clin Exp Dermatol 2006; 32: 34–8
Kaplan AP, Spector SL, Meeves S, et al. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Ann Allergy Asthma Immunol 2005; 95: 662–9
Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000; 84: 517–22
Henz BM. The pharmacologic profile of desloratadine: a review. Allergy 2001; 56 Suppl. 65: 7–13
Breneman DL. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother 1996; 30: 1075–9
Kapp A, Wedi B. Chronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizine. J Drugs Dermatol 2004; 3: 632–9
Harvey RR, Wegs J, Schocket AL. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol 1981; 68: 262–6
Tedeschi A, Airaghi L, Lorini M, et al. Chronic urticaria: a role for newer immunomodulatory drugs. Am J Clin Dermatol 2003; 4: 297–305
Hannuksela M, Kokkonen EL. Ultraviolet light therapy in chronic urticaria. Acta Derm Venereol 1985; 65: 449–50
Greene SL, Reed CE, Schroeter AL. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol 1985; 12: 669–75
Goldsobel AB, Rohr AS, Siegel SC, et al. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1986; 78 (5 Pt 1): 867–73
Thormann H, Bindslev-Jensen C. Mirtazapine for chronic urticaria. Acta Derm Venereol 2004; 84: 482–3
Kaplan AP. Chronic urticaria and angioedema. New Engl J Med 2002; 346: 175–9
Ellis MH. Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol 1998; 102: 876–7
Spector S, Tan RA. Antileukotrienes in chronic urticaria [letter]. J Allergy Clin Immunol 1998; 102 (4 Pt 1): 572
Asero R, Tedeschi A, Lorini M. Leukotriene receptor antagonists in chronic urticaria. Allergy 2001; 56: 456–7
Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 2002; 110: 484–8
Asero R. Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria. Ann Allergy Asthma Immunol 2000; 85: 156–7
Nettis E, Colanardi MC, Paradiso MT, et al. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy 2004; 34: 1401–7
Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 2004; 113: 134–40
Reimers A, Pichler C, Helbling A, et al. Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Exp Allergy 2002; 32: 1763–8
Bressler RB, Sowell K, Huston DP. Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial. J Allergy Clin Immunol 1989; 83 (4): 756–63
Di Gioacchino M, Di Stefano F, Cavallucci E, et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc 2003; 24: 285–90
Grattan CE, O’Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria. Br J Dermatol 2000; 143: 365–72
Stanaland BE. Treatment of patients with chronic idiopathic urticaria. Clin Rev Allergy Immunol 2002; 23: 233–41
Bernstein JA, Garramone SM, Lower EG. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide. Ann Allergy Asthma Immunol 2002; 89: 212–4
Gach JE, Sabroe RA, Greaves MW, et al. Methotrexate-responsive chronic idio-pathic urticaria: a report of two cases. Br J Dermatol 2001; 145: 340–3
Shahar E, Bergman R, Guttman-Yassky E, et al. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. Int J Dermatol 2006; 45: 1224–7
Klote MM, Nelson MR, Engler RJ. Autoimmune urticaria response to high-dose intravenous immunoglobulin. Ann Allergy Asthma Immunol 2005; 94: 307–8
O’Donnell BF, Barr RM, Black AK, et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998; 138: 101–6
Asero R. Are IVIg for chronic unremitting urticaria effective? Allergy 2000; 55: 1099–101
Grattan CE, Francis DM, Slater NG, et al. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992; 339: 1078–80
Boehm I, Bauer R, Bieber T. Urticaria treated with dapsone. Allergy 1999; 54: 765–6
Cassano N, D’Argento V, Filotico R, et al. Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study. Acta Derm Venereol 2005; 85: 254–5
Reeves GE, Boyle MJ, Bonfield J, et al. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 2004; 34: 182–6
Berth-Jones J, Hutchinson PE, Wicks AC, et al. Chronic urticaria with angio-oedema controlled by warfarin. BMJ 1988; 297: 1382–3
Parslew R, Pryce D, Ashworth J, et al. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy 2000; 30: 1161–5
Barlow RJ, Greaves MW. Warfarin in the treatment of chronic urticaria/angio-edema. Br J Dermatol 1992; 126: 415–6
Spector SL, Tan RA. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 2007; 99: 90–3
Gimenez-Arnau A, Pujol RM, Ianosi S, et al. Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study. Allergy 2007; 62 (5): 539–46
Dunford PJ, Williams KN, Desai PJ, et al. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 2007; 119 (1): 176–83
Acknowledgments
No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.2165/11630190-000000000-00000.
Rights and permissions
About this article
Cite this article
Poonawalla, T., Kelly, B. Urticaria. Am J Clin Dermatol 10, 9–21 (2009). https://doi.org/10.2165/0128071-200910010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/0128071-200910010-00002